Deutsche Bank Aktiengesellschaft »

Prelude Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-12-31 $159k 124k 1.28
2024-09-30 $30k 15k 2.07
2024-06-30 $56k 15k 3.81
2023-09-30 $1.4k 446 3.09
2022-03-31 $40k 6.2k 6.49
2021-12-31 $89k 6.9k 12.99
2021-09-30 $212k 6.5k 32.47
2021-06-30 $1.1M 37k 29.22
2021-03-31 $1.5M 37k 42.21
2020-12-31 $482k 6.8k 71.43